Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

OncoGenex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ONCOGENEX PHARMACEUTICALS, INCORPORATION (OGXI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Mar 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-drugs(OGXI)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Mar 2015 ValuEngine, Inc. 10 $49.00

OGXI: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

26 Mar 2015 New Constructs, LLC 9 $25.00

ValuEngine Rating and Forecast Report for OGXI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

23 Mar 2015 ValuEngine, Inc. 11 $25.00

OncoGenex Pharmaceuticals

21 Mar 2015 S&P Capital IQ Quantitative Report 10 $115.00

ONCOGENEX PHARMACEUTICALS INC (OGXI) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 Mar 2015 Pechala's Reports 1 $15.00

ONCOGENEX PHARMACEUTICALS INC (OGXI) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 Mar 2015 Pechala's Reports 1 $25.00

Value Graph: ONCOGENEX PHARM -- OGXI

20 Mar 2015 Ford Investor Services, Inc. 1 $12.00

ONCOGENEX PHARM (OGXI) Zacks Company Snapshot

18 Mar 2015 Zacks Investment Research Inc. 1 $12.00